Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

被引：373

作者：

Caskey, Marina ^{[1
]}

Schoofs, Till ^{[1
]}

Gruell, Henning ^{[2
,3
,4
]}

Settler, Allison ^{[1
]}

Karagounis, Theodora ^{[1
]}

Kreider, Edward F. ^{[5
,6
]}

Murrell, Ben ^{[7
]}

Pfeifer, Nico ^{[8
]}

Nogueira, Lilian ^{[1
]}

Oliveira, Thiago Y. ^{[1
]}

Learn, Gerald H. ^{[5
,6
]}

Cohen, Yehuda Z. ^{[1
]}

Lehmann, Clara ^{[3
,4
]}

Gillor, Daniel ^{[3
]}

Shimeliovich, Irma ^{[1
]}

Unson-O'Brien, Cecilia ^{[1
]}

Weiland, Daniela ^{[2
,3
,4
]}

Robles, Alexander ^{[9
]}

Kuemmerle, Tim ^{[3
]}

Wyen, Christoph ^{[3
]}

Levin, Rebeka ^{[1
]}

Witmer-Pack, Maggi ^{[1
]}

Eren, Kemal ^{[10
,11
]}

Ignacio, Caroline ^{[7
]}

Kiss, Szilard ^{[12
]}

West, Anthony P., Jr. ^{[13
]}

Mouquet, Hugo ^{[14
]}

Zingman, Barry S. ^{[15
,16
]}

Gulick, Roy M. ^{[17
]}

Keler, Tibor ^{[18
]}

Bjorkman, Pamela J. ^{[13
]}

Seaman, Michael S. ^{[9
]}

Hahn, Beatrice H. ^{[5
,6
]}

Faetkenheuer, Gerd ^{[3
,4
]}

Schlesinger, Sarah J. ^{[1
]}

Nussenzweig, Michel C. ^{[1
,19
]}

Klein, Florian ^{[2
,3
,4
]}

机构：

[1] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA

[2] Univ Cologne, Expt Immunol Lab, Ctr Mol Med Cologne, Cologne, Germany

[3] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

[4] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany

[5] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA

[6] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA

[7] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA

[8] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany

[9] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA

[10] Univ Calif San Diego, Dept Biomed Informat, San Diego, CA USA

[11] Univ Calif San Diego, Bioinformat & Syst Biol, San Diego, CA 92103 USA

[12] Cornell Univ, Weill Carnell Med Coll, Dept Ophthalmol, New York, NY 10021 USA

[13] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA

[14] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, Paris, France

[15] Montefiore Med Ctr, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA

[16] Einstein Rockefeller CUNY Ctr AIDS Res, Bronx, NY USA

[17] Weill Cornell Med, Div Infect Dis, New York, NY USA

[18] Celldex Therapeut, Hampton, VA USA

[19] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA

来源：

NATURE MEDICINE | 2017年 / 23卷 / 02期

基金：

欧洲研究理事会; 美国国家卫生研究院;

关键词：

BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; HIV-1; VACCINE; GLYCAN RECOGNITION; PASSIVE TRANSFER; IN-VIVO; POTENT; VRC01; THERAPY; PHARMACOKINETICS;

D O I：

10.1038/nm.4268

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Monoclonal antibody 10-1074 targets the V3 glycan supersite on the HIV-1 envelope (Env) protein. It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far. Here we report on its safety and activity in 33 individuals who received a single intravenous infusion of the antibody. 10-1074 was well tolerated and had a half-life of 24.0 d in participants without HIV-1 infection and 12.8 d in individuals with HIV-1 infection. Thirteen individuals with viremia received the highest dose of 30 mg/kg 10-1074. Eleven of these participants were 10-1074-sensitive and showed a rapid decline in viremia by a mean of 1.52 logic copies/ml. Virologic analysis revealed the emergence of multiple independent 10-1074-resistant viruses in the first weeks after infusion. Emerging escape variants were generally resistant to the related V3-specific antibody PGT121, but remained sensitive to antibodies targeting nonoverlapping epitopes, such as the anti-CD4-binding-site antibodies 3BNC117 and VRC01. The results demonstrate the safety and activity of 10-1074 in humans and support the idea that antibodies targeting the V3 glycan supersite might be useful for the treatment and prevention of HIV-1 infection.

引用

页码：185 / 191

页数：7

共 50 条

[1] Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey
Till Schoofs
Henning Gruell
Allison Settler
Theodora Karagounis
Edward F Kreider
Ben Murrell
Nico Pfeifer
Lilian Nogueira
Thiago Y Oliveira
Gerald H Learn
Yehuda Z Cohen
Clara Lehmann
Daniel Gillor
Irina Shimeliovich
Cecilia Unson-O'Brien
Daniela Weiland
Alexander Robles
Tim Kümmerle
Christoph Wyen
Rebeka Levin
Maggi Witmer-Pack
Kemal Eren
Caroline Ignacio
Szilard Kiss
Anthony P West
Hugo Mouquet
Barry S Zingman
Roy M Gulick
Tibor Keler
Pamela J Bjorkman
Michael S Seaman
Beatrice H Hahn
Gerd Fätkenheuer
Sarah J Schlesinger
Michel C Nussenzweig
Florian Klein
Nature Medicine, 2017, 23 : 185 - 191
[2] PLASMA VIREMIA IN SERONEGATIVE HIV-1-INFECTED INDIVIDUALS
ENSOLI, F
FIORELLI, V
MEZZAROMA, I
DOFFIZI, G
RAINALDI, L
LUZI, G
FIORILLI, M
AIUTI, F
AIDS, 1991, 5 (10) : 1195 - 1199
[3] Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals
Lévy, Y
Durier, C
Lascaux, AS
Meiffrédy, V
Gahéry-Ségard, H
Goujard, C
Rouzioux, C
Resch, M
Guillet, JG
Kazatchkine, M
Delfraissy, JF
Aboulker, JP
AIDS, 2006, 20 (03) : 405 - 413
[4] MICROSPORIDIOSIS IN HIV-1-INFECTED INDIVIDUALS
BLANSHARD, C
GAZZARD, BG
LANCET, 1991, 337 (8755): : 1488 - 1489
[5] JC virus antibody and viremia as predictors of PML in HIV-1 infected individuals
Viscidi, Raphael P.
Khanna, Nina
Tan, Chen S.
Li, Xiuhung
Jacobson, Lisa
Clifford, David B.
Nath, Avindra
Margolick, Joseph B.
Shah, Keerti V.
Hirsch, Hans H.
Koralnik, Igor J.
JOURNAL OF NEUROVIROLOGY, 2010, 16 : 89 - 89
[6] Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremia
Ross, L
Johnson, M
DeMasi, R
Liao, QM
Graham, N
Shaefer, M
St Clair, M
AIDS, 2000, 14 (07) : 813 - 819
[7] The antibody response in HIV-1-infected donors
Richardson, Simone I.
Moore, Penny L.
CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) : 233 - 239
[8] Demographics and natural history of HIV-1-infected spontaneous controllers of viremia
Yang, Otto O.
Cumberland, William G.
Escobar, Robert
Liao, Diana
Chew, Kara W.
AIDS, 2017, 31 (08) : 1090 - 1097
[9] MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy
Blankson, JN
Siliciano, RF
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05): : 549 - 551
[10] Regaining of the functions of antibodies in HIV-1-infected individuals
Yu, Qigui
Hu, Weiguo
Hu, Ningjie
Byrd, Daniel
Amet, Tohti
Qin, Xuebin
JOURNAL OF IMMUNOLOGY, 2010, 184

← 1 2 3 4 5 →